OP0233 EFFICACY, SAFETY, AND PHARMACODYNAMIC EFFECTS OF THE BRUTON'S TYROSINE KINASE INHIBITOR, FENEBRUTINIB (GDC-0853), IN MODERATE TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS IN A PHASE 2 CONTROLLED STUDY

David Isenberg, Richard Furie, Nicholas S. Jones, Pascal Guibord, Joshua Galanter, C. Lee, Anna G McGregor, Balázs István Tóth, Julie Rae, Olivia Hwang, Armend Lokku, Pedro C. Miranda, Viviane de Oliveira Nogueira Souza, Juan José Jaller-Raad, A. Fernandes, Rodrigo García Salinas, Leslie W. Chinn, Michael J. Townsend, Alyssa Morimoto, Katie Tuckwell